Top Markets
Coin of the day
Genenta Science S.p.A. Genenta Science S.p.A.

Genenta Science S.p.A.

GNTA
Classement en actions #28060
Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused... Genenta Science S.p.A. is an Italian clinical-stage biotechnology firm focused on pioneering hematopoietic stem cell gene therapies to combat solid tumors. Its primary therapeutic candidate, Temferon, is currently undergoing Phase 1/2a clinical evaluation. This innovative therapy is being developed to treat glioblastoma multiforme, specifically targeting patients whose tumors exhibit an unmethylated MGMT gene promoter. Beyond this, Genenta Science is exploring Temferon's potential application in various other solid tumor types, including locally advanced hepatocellular carcinoma and intra-hepatic cholangiocarcinoma. Established in 2014, the company maintains its headquarters in Milan, Italy.
Prix de l'action
$1.51
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$28.82M
Changement (1 jour)
-0.33%
Changement (1 an)
-57.49%
Pays
IT
Échange Genenta Science S.p.A. (GNTA)

Catégorie

Historique du prix de l'action pour Genenta Science S.p.A. (GNTA)
Prix de clôture le plus élevé : $1.55 le 2026-07-01

Prix de clôture le plus bas : $11.33 le 2021-12-01
Historique du prix de l'action de Genenta Science S.p.A. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 7.52%
2025 -68.48%
2024 -0.35%
2023 -6.83%
2022 -51.72%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$123.22 -13.24%
AU
$753.28 5.84%
CH